Invasive fungal infections – Page 10

Speciation analysis of fungi by liquid atmospheric pressure MALDI mass spectrometry

mycolabadmin

Scientists developed a fast new method using a technique called LAP-MALDI mass spectrometry to identify dangerous fungal infections within minutes instead of days. The method analyzes the unique fatty acids and proteins in fungal cells to distinguish between different species. This could help doctors quickly identify which fungal infection a patient has and choose the right treatment, potentially saving lives.

Quality improvement project to reduce beta-D-glucan turnaround times in an NHS pathology network

mycolabadmin

Hospitals were taking too long to get results for a fungal blood test (beta-D-glucan) that helps doctors decide whether patients with serious infections need antifungal medicines. A UK hospital pathology network improved this by bringing the test in-house instead of sending samples to a distant reference laboratory. After implementing the new system, they cut the average wait time from over 11 days to just 2.5 days while also saving money, allowing doctors to make faster treatment decisions for critically ill patients.

Olorofim activity against multidrug-resistant Fusarium unveils intra-species and inter-species variability

mycolabadmin

Researchers tested a new antifungal drug called olorofim against 253 different Fusarium fungi that infect humans. Fusarium is particularly dangerous for people with weakened immune systems and resists most common antifungals. The study found that olorofim works, but its effectiveness varies significantly depending on which type of Fusarium is present. While these lab results are promising, additional testing in animal models is needed before it can be used clinically.

Fungal β-Glucans: Biological Properties, Immunomodulatory Effects, Diagnostic and Therapeutic Applications

mycolabadmin

β-glucans are natural substances found in yeast and fungi that help boost the immune system and fight cancer. They can be measured in blood to diagnose serious fungal infections and may help prevent common illnesses like colds and respiratory infections. Recent research suggests they could be useful additions to vaccines and may help patients recovering from COVID-19.

One for All and All for One: Multikingdom Interplay in Severe Viral Pneumonia

mycolabadmin

This editorial discusses how bacteria, viruses, and fungi interact in the lungs during severe pneumonia from COVID-19 or influenza. When mechanically ventilated patients with COVID-19 had bacterial infections detected, their immune systems released more inflammatory chemicals. However, the same pattern was not observed in influenza patients. Understanding how all these microorganisms work together may help doctors better treat these serious lung infections.

Clinical Outcomes of Micafungin for Invasive Fungal Infections in the Obese and Nonobese

mycolabadmin

This study examined whether obese patients treated with the antifungal drug micafungin for serious fungal infections had different outcomes compared to non-obese patients. Researchers reviewed 378 patient cases and found that both groups had similar success rates of about 50%, suggesting that the standard dose of micafungin works equally well in obese and non-obese patients. These findings suggest that doctors do not need to prescribe higher doses of micafungin specifically for obese patients, though more research is needed to fully understand how obesity affects antifungal treatment.

Incidence And Risk Factors for Invasive Fungal Infections in Pre-Transplant and Transplant-Ineligible Multiple Myeloma in the U.S.: A Claims Analysis (2017-2021)

mycolabadmin

This study examined fungal infections in patients with multiple myeloma who were not eligible for or preparing for stem cell transplants. Researchers found that 6% of these patients developed invasive fungal infections, with yeast infections being the most common type. The risk of these infections was significantly higher in patients taking dexamethasone (a steroid) or those with low white blood cell counts and those receiving multiple cancer therapies.

Time- and temperature-dependent Pentraxin 3 stability in serum and bronchoalveolar lavage fluid samples

mycolabadmin

This study investigated how stable Pentraxin 3 (Ptx3), a protein used to detect fungal infections, remains when stored at different temperatures. Researchers found that Ptx3 stays reliable for up to 8 months in freezer storage at −20°C and even longer at −80°C, making it a dependable biomarker for diagnosing serious fungal infections. However, storing samples at room temperature (37°C) causes the protein to break down quickly, so proper cold storage is essential for accurate test results.

Efficacy and safety of isavuconazole for invasive fungal infections: A systematic review and meta-analysis of randomized controlled trials

mycolabadmin

Isavuconazole is an antifungal medication used to treat serious fungal infections in people with weakened immune systems. This study reviewed and analyzed three clinical trials to compare how well isavuconazole works compared to other antifungal drugs. The results showed that isavuconazole is just as effective as other antifungals but has fewer side effects, particularly fewer problems with liver health and drug-related adverse events. This makes isavuconazole a good alternative choice for patients who cannot use other antifungal medications or who are at risk of liver damage.

Pan-Indian Clinical Registry of Invasive Fungal Infections Among Patients in the Intensive Care Unit: Protocol for a Multicentric Prospective Study

mycolabadmin

Fungal infections are a serious hidden threat in hospital intensive care units, particularly for patients with weakened immune systems. This study establishes India’s first comprehensive database system to track fungal infections across 8 major medical centers nationwide. By collecting detailed information about these infections and how they respond to treatments, the research aims to help doctors diagnose and treat fungal infections faster and more effectively. The findings will guide better clinical practices and public health policies to combat these often-neglected but deadly infections.

Disease: Invasive fungal infections